A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Citadel Advisors LLC holds 261,400 shares of ARKG stock, worth $6.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
261,400
Previous 385,500 32.19%
Holding current value
$6.34 Million
Previous $12.6 Million 40.57%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$27.9 - $32.96 $8.58 Million - $10.1 Million
307,423 New
307,423 $8.84 Million
Q3 2023

Nov 14, 2023

SELL
$27.6 - $38.18 $1.53 Million - $2.12 Million
-55,557 Reduced 30.14%
128,754 $3.59 Million
Q2 2023

Aug 14, 2023

BUY
$28.26 - $35.21 $3.82 Million - $4.76 Million
135,327 Added 276.27%
184,311 $6.28 Million
Q1 2023

May 15, 2023

SELL
$27.46 - $36.49 $1.97 Million - $2.62 Million
-71,718 Reduced 59.42%
48,984 $1.47 Million
Q4 2022

Feb 14, 2023

SELL
$27.08 - $36.23 $7.77 Million - $10.4 Million
-287,014 Reduced 70.4%
120,702 $3.41 Million
Q3 2022

Nov 14, 2022

SELL
$32.14 - $42.39 $1.99 Million - $2.62 Million
-61,789 Reduced 13.16%
407,716 $13.4 Million
Q2 2022

Aug 15, 2022

BUY
$27.2 - $48.94 $11.9 Million - $21.4 Million
436,404 Added 1318.4%
469,505 $14.8 Million
Q1 2022

May 16, 2022

SELL
$38.15 - $63.26 $10.4 Million - $17.3 Million
-273,758 Reduced 89.21%
33,101 $1.52 Million
Q3 2021

Nov 15, 2021

BUY
$73.87 - $92.86 $16.3 Million - $20.5 Million
221,243 Added 258.41%
306,859 $22.9 Million
Q2 2021

Aug 16, 2021

BUY
$73.64 - $93.1 $3.72 Million - $4.7 Million
50,490 Added 143.74%
85,616 $7.92 Million
Q1 2021

May 17, 2021

BUY
$81.74 - $112.47 $2.21 Million - $3.04 Million
27,011 Added 332.85%
35,126 $3.12 Million
Q3 2020

Nov 16, 2020

BUY
$53.19 - $64.24 $431,636 - $521,307
8,115 New
8,115 $517,000
Q2 2020

Aug 14, 2020

SELL
$29.13 - $53.08 $605,729 - $1.1 Million
-20,794 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$24.5 - $37.69 $509,453 - $783,725
20,794 New
20,794 $650,000
Q4 2019

Feb 14, 2020

SELL
$27.95 - $36.43 $1.17 Million - $1.53 Million
-41,964 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$29.35 - $35.25 $574,232 - $689,666
19,565 Added 87.35%
41,964 $1.24 Million
Q2 2019

Aug 14, 2019

SELL
$29.12 - $34.56 $686,649 - $814,924
-23,580 Reduced 51.28%
22,399 $772,000
Q4 2018

Feb 14, 2019

BUY
$22.36 - $32.61 $257,900 - $376,123
11,534 Added 33.49%
45,979 $1.1 Million
Q2 2018

Aug 10, 2018

BUY
$24.81 - $31.58 $854,580 - $1.09 Million
34,445 New
34,445 $0

Others Institutions Holding ARKG

About ARK GENOMIC REVOLUTION ETF (DE


  • Ticker ARKG
  • Sector ETFs
  • Industry ETFs
More about ARKG
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.